241 results on '"Cordido F"'
Search Results
2. Changes in Hypothalamic Expression of the Lin28/let-7 System and Related MicroRNAs During Postnatal Maturation and After Experimental Manipulations of Puberty
3. Growth Hormone Deficiency in Obesity Is Associated to Cardiometabolic Risk Factors.
4. Influence of Ghrelin and Growth Hormone Deficiency on AMP-Activated Protein Kinase and Hypothalamic Lipid Metabolism
5. Acute changes in free-fatty acids (FFA) do not alter serum leptin levels
6. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1
7. Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients
8. Atypical thymic carcinoid in multiple endocrine neoplasia type 1 syndrome
9. The use of growth hormone (GH) secretagogues in the diagnosis of GH deficiency in humans
10. Alteraciones neuroendocrinas en la obesidad
11. Cost-Effectiveness Analysis of Second-Line Pharmacological Treatments of Acromegaly In Spain
12. FNDC5 expression and circulating irisin levels are modified by diet and hormonal conditions in hypothalamus, adipose tissue and muscle
13. Testicular expression of the Lin28/let-7 system: Hormonal regulation and changes during postnatal maturation and after manipulations of puberty
14. PSY75 - Cost-Effectiveness Analysis of Second-Line Pharmacological Treatments of Acromegaly In Spain
15. Importance of Exercise in the Control of Metabolic and Inflammatory Parameters at the Moment of Onset in Type 1 Diabetic Subjects
16. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test
17. Regulation of growth hormone secretion by signals produced by the adipose tissue
18. Sexual Dimorphism on Growth Hormone Secretion after Oral Glucose Administration
19. Growth Hormone, Ghrelin and Peptide YY Secretion after Oral Glucose Administration in Healthy and Obese Women
20. Effect of low-GDP bicarbonate-lactate-buffered peritoneal dialysis solutions on plasma levels of adipokines and gut appetite-regulatory peptides. A randomized crossover study
21. Ghrelin and lipid metabolism: key partners in energy balance
22. Short-term regulation of peptide YY secretion by a mixed meal or peritoneal glucose-based dialysate in patients with chronic renal failure
23. Incidentalomas hipofisarios
24. Acromegalia que simula un neuroblastoma
25. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis
26. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients
27. Secreción de la hormona del crecimiento en la diabetes mellitus
28. Carcinoma papilar
29. Tirotoxicosis por amiodarona. ¿Está todo dicho?
30. Relationship between the growth hormone-insulin-like growth factor I axis and serum leptin in patients with chronic renal failure
31. Growth hormone (GH) secretion in GH-deficientadults and obese patients: Effect of the administration of acipimox on GH secretion mediated by GH-releasing hormone
32. Growth hormone secretion in patients withacromegaly: Effect of acute administration of acipimox
33. Prevalence of pregnancy and postpartum thyroid dysfunction in a homogeneous population of Spain
34. Effect of Acute Pharmacological Reduction of Plasma Free Fatty Acids on Growth Hormone (GH) Releasing Hormone-Induced GH Secretion in Obese Adults with and without Hypopituitarism
35. Hypopituitarism due to lymphocytic hypophysitis in a patient with retroperitoneal fibrosis
36. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli.
37. Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression
38. MRI of Mediastinal Parathyroid Cystic Adenoma Causing Hyperparathyroidism
39. Effect of combined administration of growth hormone (GH)-releasing hormone, GH-releasing peptide-6, and pyridostigmine in normal and obese subjects
40. Amyloid goitre: CT and MR findings
41. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
42. Regulation of Growth Hormone Secretion by the Growth Hormone Releasing Hexapeptide (GHRP-6)
43. EFFECT OF ENHANCEMENT OF ENDOGENOUS CHOLINERGIC TONE WITH PYRIDOSTIGMINE ON GROWTH HORMONE (GH) RESPONSES TO GH-RELEASING HORMONE IN PATIENTS WITH CUSHING'S SYNDROME
44. Differential Effects of Direct and Indirectly Acting Cholinergic Agonists on Growth Hormone Release in Man, and Lack of Effect on Cortisol Secretion.
45. Long-term hormonal adaptations to weight loss.
46. Effect of the application of the new diagnostic criteria of diabetes mellitus in the prevalence estimates and diagnostic level in the general population.
47. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
48. Food intake regulating-neuropeptides are expressed and regulated through pregnancy and following food restriction in rat placenta
49. Study of β-cell Function and Erythrocyte Insulin Receptors in a Patient with Diabetic Ketoacidosis Associated with L-asparaginase Therapy.
50. Insulin regimens in type 2 diabetes.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.